Best Life Sciences Tech Companies in Connecticut, United States
The 38 best Life Sciences Tech companies in Connecticut, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Bexorg.
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Connecticut
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Bexorg Developer of whole-brain perfusion model for drug discovery | $23M | 10 mo ago | Series A | Zvonimir Vrselja CEO | 2021 | Apple iCloud MailGoogle WorkspaceNode.js+14 | 8 patents Advanced organ perfusion systems and AI-driven brain perfusion modeling for medical therapies | — |
| 2 | Core Informatics Laboratory data management and bioinformatics solutions for life science research | $22M | 133 mo ago | Acqui-Hired | — | 2005 | — | — | — |
| 3 | Jumo Health Provider of healthcare education and clinical trial solutions for patients and professionals | $13M | 24 mo ago | Series A | Brittany Erana CEO | 2009 | WordPressMySQLPHP+16 | — | — |
| 4 | Weave AI-powered platform to accelerate investigational new drug submission | $10M | 10 mo ago | Series A | Umut Eser Co-Founder & Chief AI Officer | 2022 | — | — | — |
| 5 | Cytosolix Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors | $7M | 38 mo ago | Series A | John Deacon Founder | 2017 | — | — | — |
| 6 | RxAll AI platform to authenticate medicines & a platform to enable pharmacy procurement | $5M | 61 mo ago | Seed | Adebayo Alonge Co-Founder & CEO | 2015 | WordPressMySQLPHP+12 | — | 2 job openings |
| 7 | inveniai Developer of an artificial intelligence platform for drug discovery and development | $3M | 26 mo ago | Funding Raised | — | 2017 | — | 2 patents Pharmaceutical compositions and methods for treating inflammatory and gastrointestinal diseases | — |
| 8 | AtlasXomics Provider of omics data analysis platform | $2M | 14 mo ago | Seed | — | 2019 | Cart FunctionalitySquarespace CommerceSquarespace+17 | 13 patents Microfluidic chiplet platforms enabling high‑throughput, spatially encoded tissue assay screening | — |
| 9 | CMDBioscience DNA/RNA synthesis services, modifications, oligos, and related products provider | $925K | 165 mo ago | Deadpooled | Joseph Audie Co-Founder & CEO | 2006 | — | — | — |
| 10 | Compliance Control SaaS-based compliance management software for pharmaceuticals and Life sciences | $501K | 163 mo ago | Deadpooled | David Forrest Founder | 2003 | — | — | — |
| 11 | Smpl Bio Provider of bioinformatics platform for genomics and proteomics analysis | $500K | 129 mo ago | Deadpooled | Edward Hemphill Co-Founder | 2014 | — | — | — |
| 12 | KovaDx Provider of an AI based health monitoring and red blood cell diseases diagnostic tool for providers | $256K | 61 mo ago | Funding Raised | Yaw Ofosu Ansong CEO | 2020 | — | 4 patents Blood diagnostic assays for hemolytic anemia and related hematologic disorders | — |
| 13 | Cerno Bioscience Mass spectrometry software enhancing performance, streamlining analysis, and accelerating scientific discovery | $216K | 155 mo ago | Funding Raised | Yongdong Wang Founder & President | 2003 | — | 68 patents Automated LC‑MS data acquisition, calibration, and spectral library searching for complex mixtures | — |
Top 12 Life Sciences Tech companies in Connecticut
#1
Series A · New Haven, Connecticut · founded 2021$23Mraised▾
Developer of whole-brain perfusion model for drug discovery. The company's proprietary technology transforms brains into discovery machines by perfusing whole human and porcine brains, generating highly dimensional datasets consisting of cellular responses.
- Oct 2025Series A$23M
#2
Series A · New Haven, Connecticut · founded 2022 · 9 employees$10Mraised▾
AI-powered platform to accelerate investigational new drug submission. The platform accelerate document drafting, navigate complex source documents, streamline reviews, and automatic content updates. It has applications for pharmaceutical companies, biotech, and regulatory consultants.
- Oct 2025Series A$20M
- May 2024Seed$10M
- Aug 2022Seed$1.6M
#3
Seed · New Haven, Connecticut · founded 2019 · 22 employees$1.8Mraised▾
Provider of omics data analysis platform. It offers a drug discovery platform for clinicians and researchers to analyze multi-omics data like transcriptomic, proteomic, and epigenomics.
- Jun 2025Grant (prize money)$400K
- May 2025Grant (prize money)$399.9K
- Jul 2024Grant (prize money)$399.9K
- Mar 2024Grant (prize money)$400K
#4
Series A · New Haven, Connecticut · founded 2009 · 86 employees$12.5Mraised▾
Jumo Health develops educational resources for patients and clinical trial solutions for researchers. The contents on the platform are written by the staff of doctors, peer-reviewed by leading specialists, and endorsed by patient association and advocacy groups and cover a wide range of therapeutic areas, including rare diseases. The platform assists researchers to approach partici[ants for clinical trial and address the patient recruitment process. The company uses visual aids and study protocol for the clinical trial recruitment process.
- Aug 2024PE—
- Aug 2020Series A$2.3M
- Apr 2018Series A$2.5M
- Feb 2015Series A$1.3M
#5
Funding Raised · Guilford, Connecticut · founded 2017 · 45 employees$3.1Mraised▾
Developer of an artificial intelligence platform for drug discovery and development. The platform integrates scientific, medical, chemical, and biological data. This allows experts to search for treatment options. The platform enables prioritization of biological targets and modalities with disease indications. It maximizes safety and efficacy.
- Jun 2024Conventional Debt$3.1M
#6
Series A · Tolland, Connecticut · founded 2017 · 4 employees$6.6Mraised▾
Provider of a re-engineering platform for the existing chemotherapeutics to target solid tumors. It provides the tumor-activated permeability (TAP) System, which creates weakly acidic derivatives of well-known oncology medications that boost uptake by cancer cells while limiting uptake by healthy cells.
- Jun 2023Series A$6.6M
#7
Acqui-Hired · Branford, Connecticut · founded 2005 · 43 employees$22.5Mraised▾
Laboratory data management and bioinformatics solutions for life science research. Core Informatics' solutions and products are web or cloud-based, scalable, and highly configurable software that allows customers to manage data end-to-end across workflows. The company's product line includes Core LIMS (a laboratory information management system), Core ELN (a cloud-based electronic laboratory notebook for Biology or Chemistry), Core Collaboration (collaboration tool for business, IT, or research), and Core SDMS (a scientific data management software - an automated data capture framework that integrates the company's flagship cloud-based Platform for Science platform with laboratory instruments and workflows.
- Jul 2015Series B$17.5M
- Jun 2014Series A$5M
#8
Seed · New Haven, Connecticut · founded 2015 · 28 employees$5.3Mraised▾
RxAll is developing an AI-based algorithm platform that enables spectrometer devices to authenticate medicines in real-time. Its AI platform leverages deep learning and works through spectrometers & a cloud dataset of spectral signatures of medicines to carry out non-destructive product authentication. It is a digital platform that enables hospitals and retail pharmacies to order authentic stock from verified pharmaceutical manufacturers and wholesalers.
- Jul 2021Seed$3.1M
- Jun 2021Seed$2M
- 2019Seed—
- Feb 2018Seed$150K
#9
Deadpooled · New Haven, Connecticut · founded 2006 · 6 employees$925Kraised▾
DNA/RNA synthesis services, modifications, oligos, and related products provider. They offer a universal DNA & RNA synthesis service with a range of modifications. They provide guaranteed oligos, deprotected, desalted, and PAGE controlled, with additional purifications available. Their offerings include non-labeled and fluorescently labeled DNA, as well as non-fluorescent labels and other modifications. They also provide LightCycler Hybridization Probes, Taqman Hybridization Probes, S-Oligos, RNA/2'O-methyl Mixed Oligos, and Mass Oligos. They offer bulk oligos, standard or purified. They also provide services to improve workspace design and ergonomics consulting business. They help management to optimize their time and employee to be more efficient and more productive.
- Nov 2012Seed$775K
- Feb 2011Seed$150K
#10
Funding Raised · New Haven, Connecticut · founded 2020 · 5 employees$255.9Kraised▾
Provider of an AI based health monitoring and red blood cell diseases diagnostic tool for providers. The company has developed a disease diagnostic tool that allows the monitoring of patient health using 3D Quantitative Phase Imaging. The system generated and obtains data from the cell after the imaging process using AI technology in the software.
- Aug 2021Grant (prize money)$255.9K
- 2020Grant (prize money)—
#11
Deadpooled · Cheshire, Connecticut · founded 2003 · 11 employees$501Kraised▾
Compliance control provides saas-based software solution for pharma and life sciences industry to ensure compliance with ever changing regulatory standards. Compliance Controlcentre suite provides electronic document management (document capture, indexing for discovery) and quality management software(track non-compliance). The capabilities are store and retrieve documents, GAMP5 training, CAPA, Auditing, Reporting, Alerts, non-conformance, compliance and cGARD. cGARD provides access to list of up-to-date regulations and standards.
- Jan 2013Seed$322.7K
- Oct 2012Seed$177.8K
#12
Deadpooled · Tolland, Connecticut · founded 2014$500Kraised▾
Smpl Bio is developing Kratos bioinformatics platform for genomics and proteomics analysis. The platform has applications in single-cell analysis, omics research, biopharmaceuticals, translational research and companion diagnostics, plant genomics, personalized medicine, and diagnostics. The toolkit facilitates rapid and effective experimental design through biomarker selection, quality control, and informative visualizations.
- Nov 2015Seed$500K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
What Connecticut researches in biotechnology
- University of Connecticut17
- Connecticut Agricultural Experiment Station12
- Connecticut Sea Grant1
- VA Connecticut Healthcare System1
- Southern Connecticut State University1
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.